Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Regulatory News:
Orexo AB (STO:ORX) announces today that it has appointed Robert A. DeLuca, as President of Orexo US Inc., a fully owned US subsidiary of Orexo AB. Orexo US Inc will focus on commercialization of Zubsolv™ (buprenorphine and naloxone, sublingual tablets) in collaboration with the appointed partner Publicis Touchpoint Solutions. With the establishment of a commercial leadership team in the US, Orexo AB in Sweden will focus its resources on the development of new products including product extensions of Zubsolv, manufacturing and quality assurance and provide overall corporate governance. Mr. DeLuca will become a member of the Executive Management team of Orexo AB.
Help employers find you! Check out all the jobs and post your resume.
